Literature DB >> 30305739

The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter.

Brenda M Gannon1, Michael H Baumann2, Donna Walther2, Cristian Jimenez-Morigosa2, Agnieszka Sulima3, Kenner C Rice3, Gregory T Collins4,5.   

Abstract

Synthetic cathinones are common constituents of abused "bath salts" preparations and represent a large family of structurally related compounds that function as cocaine-like inhibitors or amphetamine-like substrates of dopamine (DAT), norepinephrine (NET), and serotonin (SERT) transporters. Preclinical evidence suggests that some cathinones (e.g., MDPV and α-PVP) are more effective reinforcers than prototypical stimulant drugs of abuse, such as cocaine or methamphetamine. Although the reinforcing potency of these cathinones is related to their potency to inhibit DAT, less is known about the pharmacological determinants of their unusually high reinforcing effectiveness. To this end, we tested the hypothesis that reinforcing effectiveness of cathinone stimulants is positively correlated with their selectivity for DAT relative to SERT. Uptake inhibition assays in rat brain synaptosomes were used to directly compare the potency of MDPV, MDPBP, MDPPP, α-PVP, α-PPP, and cocaine at DAT, NET, and SERT, whereas intravenous self-administration in rats was used to quantify relative reinforcing effectiveness of the drugs using progressive ratio (PR) and behavioral economic procedures. All cathinones were more potent at DAT than NET or SERT, with a rank order for selectivity at DAT over SERT of α-PVP > α-PPP > MDPV > MDPBP > MDPPP > cocaine. These synthetic cathinones were more effective reinforcers than cocaine, and the measures of reinforcing effectiveness determined by PR and demand curve analyses were highly correlated with selectivity for DAT over SERT. Together, these studies provide strong and convergent evidence that the abuse potential of stimulant drugs is mediated by uptake inhibition at DAT, with activity at SERT serving as a negative modulator of reinforcing effectiveness.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30305739      PMCID: PMC6180085          DOI: 10.1038/s41386-018-0209-3

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  40 in total

1.  Progressive ratio and fixed ratio schedules of cocaine-maintained responding in baboons.

Authors:  R R Griffiths; L D Bradford; J V Brady
Journal:  Psychopharmacology (Berl)       Date:  1979-10       Impact factor: 4.530

2.  Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order.

Authors: 
Journal:  Fed Regist       Date:  2011-10-21

3.  Cocaine receptors on dopamine transporters are related to self-administration of cocaine.

Authors:  M C Ritz; R J Lamb; S R Goldberg; M J Kuhar
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

4.  Schedules of controlled substances: temporary placement of 10 synthetic cathinones into Schedule I. Final order.

Authors: 
Journal:  Fed Regist       Date:  2014-03-07

5.  Role of the increased noradrenergic neurotransmission in drug self-administration.

Authors:  Sunmee Wee; Zhixia Wang; Rong He; Jia Zhou; Alan P Kozikowski; William L Woolverton
Journal:  Drug Alcohol Depend       Date:  2005-10-05       Impact factor: 4.492

6.  A reduced rate of in vivo dopamine transporter binding is associated with lower relative reinforcing efficacy of stimulants.

Authors:  Sunmee Wee; F Ivy Carroll; William L Woolverton
Journal:  Neuropsychopharmacology       Date:  2006-02       Impact factor: 7.853

7.  Pharmacological characterization of designer cathinones in vitro.

Authors:  L D Simmler; T A Buser; M Donzelli; Y Schramm; L-H Dieu; J Huwyler; S Chaboz; M C Hoener; M E Liechti
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

8.  The reinforcing efficacy of psychostimulants in rhesus monkeys: the role of pharmacokinetics and pharmacodynamics.

Authors:  Joshua A Lile; Zhixia Wang; William L Woolverton; Jessica E France; Timothy C Gregg; Huw M L Davies; Michael A Nader
Journal:  J Pharmacol Exp Ther       Date:  2003-09-03       Impact factor: 4.030

9.  Monoamine transporter and receptor interaction profiles of a new series of designer cathinones.

Authors:  L D Simmler; A Rickli; M C Hoener; M E Liechti
Journal:  Neuropharmacology       Date:  2013-11-22       Impact factor: 5.250

10.  Cocaine-Like Discriminative Stimulus Effects of Mephedrone and Naphyrone in Mice.

Authors:  Brenda M Gannon; William E Fantegrossi
Journal:  J Drug Alcohol Res       Date:  2016-12-31
View more
  30 in total

1.  Emerging threats in addiction: will novel psychoactive substances contribute to exacerbating the ongoing drug overdose epidemic?

Authors:  F Scott Hall; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2019-03       Impact factor: 4.530

2.  Behavioral economic analysis of the reinforcing effects of "bath salts" mixtures: studies with MDPV, methylone, and caffeine in male Sprague-Dawley rats.

Authors:  Brenda M Gannon; Melson P Mesmin; Agnieszka Sulima; Kenner C Rice; Gregory T Collins
Journal:  Psychopharmacology (Berl)       Date:  2018-09-29       Impact factor: 4.530

3.  The synthetic cathinone psychostimulant α-PPP antagonizes serotonin 5-HT2A receptors: In vitro and in vivo evidence.

Authors:  Yiming Chen; Bruce E Blough; Kevin S Murnane; Clinton E Canal
Journal:  Drug Test Anal       Date:  2019-04-22       Impact factor: 3.345

4.  Self-administration of the synthetic cathinones 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinopentiophenone (α-PVP) in rhesus monkeys.

Authors:  Gregory T Collins; Agnieszka Sulima; Kenner C Rice; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2019-07-26       Impact factor: 4.530

5.  New designer phenethylamines 2C-C and 2C-P have abuse potential and induce neurotoxicity in rodents.

Authors:  Young-Jung Kim; Shi-Xun Ma; Kwang-Hyun Hur; Youyoung Lee; Yong-Hyun Ko; Bo-Ram Lee; Seon-Kyung Kim; Su-Jeong Sung; Kyeong-Man Kim; Hyoung-Chun Kim; Seok-Yong Lee; Choon-Gon Jang
Journal:  Arch Toxicol       Date:  2021-01-30       Impact factor: 5.153

6.  Methylenedioxypyrovalerone (MDPV) impairs working memory and alters patterns of dopamine signaling in mesocorticolimbic substrates.

Authors:  David L Bernstein; Sunyl U Nayak; Chicora F Oliver; Scott M Rawls; Slava Rom
Journal:  Neurosci Res       Date:  2019-07-11       Impact factor: 3.304

7.  "Flakka" use among high school seniors in the United States.

Authors:  Joseph J Palamar; Caroline Rutherford; Katherine M Keyes
Journal:  Drug Alcohol Depend       Date:  2019-01-29       Impact factor: 4.492

Review 8.  The effect of economy type on reinforcer value.

Authors:  David N Kearns
Journal:  Behav Processes       Date:  2019-01-24       Impact factor: 1.777

9.  The clinical challenges of synthetic cathinones.

Authors:  Fabrizio Schifano; Flavia Napoletano; Davide Arillotta; Caroline Zangani; Liam Gilgar; Amira Guirguis; John Martin Corkery; Alessandro Vento
Journal:  Br J Clin Pharmacol       Date:  2020-02-03       Impact factor: 4.335

10.  Interactions between reinforcement history and drug-primed reinstatement: Studies with MDPV and mixtures of MDPV and caffeine.

Authors:  Michelle R Doyle; Agnieszka Sulima; Kenner C Rice; Gregory T Collins
Journal:  Addict Biol       Date:  2020-04-01       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.